Repligen Corp. (RGEN)
167.77
+1.25
(+0.75%)
USD |
NASDAQ |
Nov 13, 16:00
167.77
0.00 (0.00%)
After-Hours: 19:59
Repligen Enterprise Value : 9.268B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 9.268B |
| November 11, 2026 | 9.614B |
| November 10, 2026 | 9.691B |
| November 09, 2026 | 9.972B |
| November 06, 2026 | 9.663B |
| November 05, 2026 | 9.379B |
| November 04, 2026 | 9.930B |
| November 03, 2026 | 9.934B |
| November 02, 2026 | 9.632B |
| October 30, 2026 | 9.858B |
| October 29, 2026 | 10.52B |
| October 28, 2026 | 10.30B |
| October 27, 2026 | 9.794B |
| October 26, 2026 | 10.04B |
| October 23, 2026 | 9.858B |
| October 22, 2026 | 9.959B |
| October 21, 2026 | 10.03B |
| October 20, 2026 | 9.968B |
| October 19, 2026 | 9.830B |
| October 16, 2026 | 9.772B |
| October 15, 2026 | 10.27B |
| October 14, 2026 | 9.930B |
| October 13, 2026 | 9.772B |
| October 12, 2026 | 9.607B |
| October 09, 2026 | 9.685B |
| Date | Value |
|---|---|
| October 08, 2026 | 9.116B |
| October 07, 2026 | 9.307B |
| October 06, 2026 | 9.741B |
| October 05, 2026 | 10.57B |
| October 02, 2026 | 10.13B |
| October 01, 2026 | 9.875B |
| September 30, 2026 | 10.73B |
| September 29, 2026 | 10.86B |
| September 28, 2026 | 10.83B |
| September 25, 2026 | 10.58B |
| September 24, 2026 | 10.64B |
| September 23, 2026 | 10.29B |
| September 22, 2026 | 10.42B |
| September 21, 2026 | 10.08B |
| September 18, 2026 | 9.862B |
| September 17, 2026 | 9.935B |
| September 16, 2026 | 9.637B |
| September 15, 2026 | 9.740B |
| September 14, 2026 | 9.360B |
| September 11, 2026 | 9.201B |
| September 10, 2026 | 9.173B |
| September 09, 2026 | 9.194B |
| September 08, 2026 | 9.390B |
| September 04, 2026 | 9.338B |
| September 03, 2026 | 9.451B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Anika Therapeutics, Inc. | 166.16M |
| Precigen, Inc. | 1.723B |
| Agilent Technologies, Inc. | 50.97B |
| Azenta, Inc. | 1.550B |
| Danaher Corp. | 185.41B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -38.43M |
| Revenue (Quarterly) | 209.31M |
| Total Expenses (Quarterly) | 247.75M |
| EPS Diluted (Quarterly) | -0.6795 |
| Gross Profit Margin (Quarterly) | 48.44% |
| Profit Margin (Quarterly) | -18.36% |
| Earnings Yield | -0.12% |
| Operating Earnings Yield | 0.73% |
| Normalized Earnings Yield | 0.2532 |